Other
General Anaesthesia
2
Pipeline Programs↗
4
Active Trials↗
2
Companies Involved↗
General Anaesthesia is an early-stage landscape with 2 programs across 2 companies. The most active players are Fresenius Kabi Oncology Ltd., AbbVie. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
27
clinical trials
Completed20 · 74%
Unknown status3 · 11%
Recruiting3 · 11%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
27 trials
Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect
Recruiting·—·Phase 4·NCT06631534·30 enrolled
Investigation of Cerebral Motor Activity Modulations Following Median Nerve Stimulation During General Anaesthesia
Recruiting·—·Phase 1·NCT05272202·30 enrolled
General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthroplasty
Not yet recruiting·—·Phase 4·NCT07334132·600 enrolled
Neuroplasticity Induced by General Anaesthesia
Completed·—·N/A·NCT04125121·20 enrolled
Dexmetomidine in Children Undergoing General Anaesthesia
Completed·—·N/A·NCT03923075·60 enrolled
Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia
Completed·—·Phase 4·NCT03833947·100 enrolled
Spinal Anaesthesia vs. General Anaesthesia for THA, TKA and UKA
Completed·—·Phase 4·NCT05706844·222 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)